Godbout R, Mantz J, Pirot S, Glowinski J, Thierry A M
Institut National de la Santé et de la Recherche Médicale U 114, Collège de France, Paris.
J Pharmacol Exp Ther. 1991 Aug;258(2):728-38.
Both dopaminergic (DA) and noradrenergic (NA) systems exert an inhibitory influence on the activity of prefrontal cortical neurons (PFC). As NA-containing fibers run close to the dorsal ventral tegmental area (VTA), electrical stimulation of the VTA might coactivate both DA and NA systems. In the present study extracellular recordings and microiontophoresis were used in anesthetized rats to analyze first whether the inhibitory cortical responses to VTA stimulation and DA application were mediated by DA or adrenergic receptors. Inhibitory responses elicited by DA application or VTA stimulation were observed in PFC output neurons identified by antidromic activation from subcortical structures. Both types of inhibitory effects were reversed by the DA antagonist sulpiride, but not by the adrenergic antagonists prazosin (alpha-1), yohimbine (alpha-2) or propranolol (beta). NA and the beta agonist isoproterenol inhibited the activity of PFC cells and these effects were antagonized by propranolol, but neither by prazosin and yohimbine nor by the DA antagonist sulpiride. Thus, the inhibitory influence of the mesocortical DA system in the PFC involves DA, but not NA, recognition sites. The DA receptor subtype mediating the inhibitory effects of VTA stimulation and DA application in the PFC was analyzed further. VTA- and DA-evoked inhibitory responses were antagonized by the D2 selective antagonists (-)-sulpiride, LUR 2366 and RIV 2093, but not by the D1 selective antagonist SCH23390. In addition, the DA-induced inhibitory response was mimicked by the selective D2 agonist LY 171555 but not by the selective D1 agonist SKF 38393. Surprisingly, haloperidol, which is also a potent D2 antagonist, failed to consistently block DA- and VTA-induced inhibitory effects. The present results indicate that the inhibition of PFC cells by mesocortical DA neurons is mediated via a subtype of DA receptors which is particularly sensitive to benzamides.
多巴胺能(DA)系统和去甲肾上腺素能(NA)系统均对前额叶皮质神经元(PFC)的活动产生抑制性影响。由于含NA的纤维靠近背侧腹侧被盖区(VTA),对VTA进行电刺激可能会同时激活DA系统和NA系统。在本研究中,对麻醉大鼠进行细胞外记录和微量离子透入法,首先分析皮质对VTA刺激和DA应用的抑制性反应是由DA受体还是肾上腺素能受体介导的。在通过皮层下结构逆向激活鉴定的PFC输出神经元中,观察到DA应用或VTA刺激引发的抑制性反应。两种类型的抑制作用均被DA拮抗剂舒必利逆转,但未被肾上腺素能拮抗剂哌唑嗪(α-1)、育亨宾(α-2)或普萘洛尔(β)逆转。NA和β激动剂异丙肾上腺素抑制PFC细胞的活动,这些作用被普萘洛尔拮抗,但未被哌唑嗪、育亨宾或DA拮抗剂舒必利拮抗。因此,中皮质DA系统在PFC中的抑制性影响涉及DA识别位点,而非NA识别位点。进一步分析了介导VTA刺激和DA应用在PFC中抑制作用的DA受体亚型。VTA和DA诱发的抑制性反应被D2选择性拮抗剂(-)-舒必利、LUR 2366和RIV 2093拮抗,但未被D1选择性拮抗剂SCH23390拮抗。此外,DA诱导的抑制性反应被选择性D2激动剂LY 171555模拟,但未被选择性D1激动剂SKF 38393模拟。令人惊讶的是,同样作为强效D2拮抗剂的氟哌啶醇未能始终如一地阻断DA和VTA诱导的抑制性作用。目前的结果表明,中皮质DA神经元对PFC细胞的抑制作用是通过对苯甲酰胺特别敏感的DA受体亚型介导的。